Winter Park, Florida--(Newsfile Corp. - December 17, 2025) - Adia Labs, a division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a strategic marketing partnership with BoldMD, a leading medical marketing and AI technology company focused on longevity and wellness. The partnership is designed to accelerate the nationwide expansion of Axia MD's innovative chiropractor-hosted pop-up longevity clinics.This collaboration builds on Adia Labs' recently announced partnership with Axia MD, which provides na ...

Core Insights - Adia Nutrition Inc. has partnered with Dr. Asa Andrew, a prominent health talk show host, to promote its stem cell therapies and enhance public awareness of regenerative medicine [2][5][6] Company Overview - Adia Nutrition Inc. is a publicly traded company based in Winter Park, Florida, specializing in stem cell and regenerative products, including AdiaVita and AdiaLink [6] - The company operates Adia Med clinics that focus on orthopedic, pain management, and wound repair, offering advanced treatments such as stem cell therapies and platelet-rich plasma (PRP) [6][7] Partnership Details - Dr. Asa Andrew will serve as the official media partner for Adia Med, creating exclusive content across various platforms to educate the public about stem cell therapy and its benefits [4][5] - The partnership aims to increase awareness, education, and access to life-changing treatments in the field of regenerative medicine [5][6] Business Model - Revenue for Adia Nutrition Inc. is generated through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [7] - The company is expanding its offerings to include insurance-billable wound care products through its lab division, Adia Labs LLC [6][7]

Core Insights - ADIA Nutrition, Inc. has filed a provisional patent application for a novel medical protocol aimed at enhancing regenerative outcomes, marking a significant advancement in the field of regenerative medicine [1][2]. Company Overview - ADIA Nutrition, Inc. is based in Winter Park, Florida, and is publicly traded, focusing on advanced healthcare solutions, particularly in stem cell and regenerative products [5]. - The company operates through its lab division, AdiaLabs LLC, and is expanding its offerings to include insurance-billable wound care products [5][6]. Innovation and Intellectual Property - The newly filed provisional patent represents a proprietary protocol that utilizes unique procedural and biological mechanisms not previously explored in clinical practice, positioning the company as a leader in regenerative medicine [2][3]. - Securing this patent is a crucial step for the company to protect its intellectual property and accelerate the development of next-generation health solutions [3]. Strategic Development - The patent pending status allows ADIA to pursue research, partnerships, and commercialization opportunities over the next 12 months while maintaining confidentiality [3]. - The company is actively seeking strategic partnerships and encouraging clinic owners and healthcare practitioners to integrate its regenerative therapies into their practices [4]. Revenue Generation - ADIA generates revenue through service fees, product sales, equity stakes, and billing insurance for healthcare treatments [6]. - The company is also investing in aligned businesses, such as Cement Factory LLC, which focuses on health and wellness [6].

Core Insights - Adia Nutrition Inc. has formed a strategic partnership with AxiaMD to enhance the delivery of regenerative therapies to chiropractic clinics across the United States under full physician oversight [1][2][3] Partnership Details - AxiaMD's network will provide Adia Labs' regenerative products to clients, while Adia Nutrition's clinics will benefit from AxiaMD's compliance and oversight services, ensuring operations are fully compliant across all 50 states [2][3] - This collaboration allows chiropractic clinics to perform advanced regenerative procedures with regulatory compliance, creating a scalable national platform for transformative therapies [3][4] Financial Performance - Adia Nutrition reported over 200% revenue growth in Q3 2025, indicating strong momentum leading to its OTCQB uplisting and potential Nasdaq eligibility [4] Product Offerings - Adia Labs specializes in FDA-compliant stem cell products, including AdiaVita and AdiaLink, and is expanding its offerings to include insurance-billable wound care products [5][7] - Adia Med clinics provide specialized regenerative treatments such as stem cell therapies, platelet-rich plasma (PRP), and advanced treatments like therapeutic plasma exchange (TPE) [5] Revenue Generation - The company generates revenue through service fees, product sales, equity stakes, and billing insurance for healthcare treatments, while also investing in aligned businesses like Cement Factory LLC [8]

Core Insights - Adia Nutrition Inc. has appointed Dr. Evan Thomas as Independent Medical Director for its medical division, Adia Med, to enhance specialized treatment offerings [2][5] - Dr. Thomas will oversee the Autologous Hematopoietic Stem Cell Transplantation (AHSCT) program and finalize protocols for patient intake [2][5] - The company aims to expand access to advanced stem cell solutions through strategic partnerships and licensing opportunities for clinic owners [6][8] Company Overview - Adia Nutrition Inc. is based in Winter Park, Florida, and is publicly traded, focusing on healthcare innovation [7] - The company specializes in stem cell and regenerative products, including AdiaVita and AdiaLink, and is expanding its lab division to include insurance-billable wound care products [7][8] - Adia Med clinics provide specialized regenerative treatments such as stem cell therapies, platelet-rich plasma (PRP), and therapeutic plasma exchange (TPE) [7][8] Leadership and Expertise - Dr. Evan Thomas is recognized for his expertise in oncology and has a significant background in central nervous system (CNS) and functional radiosurgery [4][5] - His leadership is expected to redefine Adia Med's impact on patient care and clinical operations [5] Revenue Generation - Adia Nutrition Inc. generates revenue through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [8]